Trade Mark Journal No.2025/051 19 December 2025
WO0000001889564 (5,42)
Office of origin: European Union Intellectual Property Office (EUIPO)
Date of International Registration:23 October 2025
Date of designation in the UK:
23 October 2025
International priority date claimed: 25 April 2025
(European Union Intellectual Property Office (EUIPO))
(019178237)
- Class 5
- Anticancer drugs; anticancer preparations; pharmaceutical products; chemico-pharmaceutical products; regenerative tissue [pharmaceutical preparations]; bacteriological preparations for pharmaceutical use; synthetic peptides for pharmaceutical use; chemical preparations for pharmaceutical use; chemical products for pharmaceutical purposes; pharmaceutical preparations containing stem cells; pharmaceutical products for cancer treatment; transdermal patches for administering pharmaceutical products; filled syringes for medical purposes containing pharmaceuticals; medical products; cells for medical use; diagnostic preparations for medical use in medical laboratories; immunoassay reagents for medical use; reagents with biomarkers for medical diagnostics; diagnostic preparations for medical use; diagnostic substances for medical use; diagnostic preparations and materials for medical and veterinary use; hygienic preparations for medical use.
- Class 42
- Scientific research; biotechnological research; biochemical research; biological research, clinical research and medical research; genetic research; chemical research; research services; pharmaceutical research and development; scientific research and development; consultancy regarding pharmaceutical research; scientific analysis and research services; research in the field of nanobiotechnology; medical and pharmacological research services; research and development of pharmaceutical preparations for treating malignant tumors; consultancy relating to pharmaceutical research and development; research in the field of pharmacogenetics; information on scientific research in the field of biochemistry and biotechnology; research and development services in immunology; research in the field of immunodeficiency; scientific and technological design; scientific design services; scientific and technological services; scientific testing services; scientific research for medical purposes; consulting in the field of scientific research; technological and scientific services; scientific laboratory services; research in the field of genetic diseases; medical research in the field of rare diseases; research in the field of gene therapies; advisory services relating to gene therapy research.
Nema Health S.L.
Representative: Clarke, Modet y Cía. S.L., C/ Suero de Quiñones, No. 34-36, E-28002 Madrid, SPAIN